Traws Pharma, Inc. 8-K

What Happened

• Traws Pharma, Inc. (TRAW) filed a Current Report on Form 8‑K on April 15, 2026 announcing results of operations and financial condition and furnishing an earnings press release dated April 15, 2026. The company included a Regulation FD disclosure that the earnings release has been broadly disseminated and is incorporated by reference into the Item 2.02 disclosure.

Key Details

• 8‑K filed April 15, 2026 reporting results of operations and financial condition (Item 2.02).
• Regulation FD Disclosure (Item 7.01) furnished the company’s earnings press release and incorporated it into the Item 2.02 disclosure.
• Press release furnished as Exhibit 99.1 (dated April 15, 2026); interactive XBRL cover page also included (Exhibit 104).

Why It Matters

• This filing signals that Traws has publicly released its recent quarterly financial results and related commentary; those details (revenue, earnings, guidance, cash position) are in the April 15 press release and are material for investors assessing performance.
• Investors should read the furnished earnings release and any accompanying SEC filings for the specific financial figures and management discussion to understand implications for Traws’ outlook and stock.